Connect with us

Survector (amineptine)

Amineptine (or SURVECTOR®) was mainly prescribed to treat major depressive disorder.


Class: Atypical, Tricyclic (TCA)

FDA Approval: International Only (Europe)

Dosage Forms: N/A

Biological Half-life: 0.8-1 hour

Side Effects: Dizziness, blurred vision, dry mouth, nausea, constipation, appetite changes, hyperhidrosis, sex drive changes

Routes of Administration: Oral

Pregnancy Category: N/A


Twitter Feed

Gene discovery may explain why Lithium doesn't work for all patients

Researchers found insomnia may increase risk of mood disorder in teens #mentalhealth @PittTweet

Can Tylenol provide relief for social media anxiety? #FOMO #socialanxiety #cyberpsychology